Cognitive Performance Clinical Trial
Official title:
Acute Effects of Ketone Monoester Supplementation on Brain Function in Older Men With Overweight
Disturbances in brain insulin-sensitivity are not only observed in obesity and type 2 diabetes (T2D), but also during brain aging and in dementia. Ketone monoester supplements may improve brain insulin-sensitivity, which can be quantified by measuring the gray-matter cerebral blood flow (CBF) response to intranasally administered insulin. We hypothesize that acute ketone monoester supplementation increases (regional) brain vascular function and insulin-sensitivity thereby improving cognitive performance and appetite control. The primary objective is to evaluate in older men the acute effect of ketone monoester supplementation on (regional) brain vascular function and insulin-sensitivity, as quantified by the non-invasive gold standard magnetic resonance imaging (MRI)-perfusion method Arterial Spin Labelling (ASL). The CBF response to intranasal insulin is a robust and sensitive physiological marker of brain insulin-sensitivity. Secondary objectives are to investigate effects on cognitive performance as assessed with a neuropsychological test battery, and appetite control as quantified by functional MRI (fMRI) with visual food cues.
Status | Not yet recruiting |
Enrollment | 18 |
Est. completion date | March 31, 2025 |
Est. primary completion date | March 31, 2025 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Male |
Age group | 60 Years to 75 Years |
Eligibility | Inclusion Criteria: - Men, aged between 60-75 years - BMI between 25-30 kg/m2 - Fasting plasma glucose < 7.0 mmol/L - Fasting serum TC < 8.0 mmol/L - Fasting serum TAG < 4.5 mmol/L - Systolic blood pressure < 160 mmHg and diastolic blood pressure < 100 mmHg - Stable body weight (weight gain or loss < 3 kg in the past three months) - Willingness to give up being a blood donor from 8 weeks before the start of the study, during the study and for 4 weeks after completion of the study - No difficult venipuncture as evidenced during the screening visit Exclusion Criteria: - Women - Left-handedness - Following a low-carbohydrate diet or consuming nutritional ketone supplements - Current smoker, or smoking cessation < 12 months - Diabetic patients - Familial hypercholesterolemia - Abuse of drugs - More than 3 alcoholic consumptions per day - Use of products or dietary supplements known to interfere with the main outcomes as judged by the principal investigators - Use medication to treat blood pressure, lipid or glucose metabolism, or neurological or mental disorders. - Use of an investigational product within another biomedical intervention trial within the previous 1-month - Severe medical conditions that might interfere with the study, such as epilepsy, asthma, kidney failure or renal insufficiency, chronic obstructive pulmonary disease, inflammatory bowel diseases, auto inflammatory diseases and rheumatoid arthritis - Active cardiovascular disease like congestive heart failure or cardiovascular event, such as an acute myocardial infarction or cerebrovascular accident - Contra-indications for MRI imaging (e.g. pacemaker, surgical clips/material in body, metal splinter in eye, claustrophobia). |
Country | Name | City | State |
---|---|---|---|
Netherlands | Maastricht University Medical Center | Maastricht | Limburg |
Lead Sponsor | Collaborator |
---|---|
Maastricht University Medical Center |
Netherlands,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Brain Vascular Function | Cerebral blood flow as quantified non-invasively by the MRI perfusion method Arterial Spin Labeling (ASL) | Change from placebo intervention at 30 minutes after supplement intake | |
Primary | Brain Insulin Sensitivity | Cerebral blood flow measurements before and after a nasal insulin spray as quantified non-invasively by the MRI perfusion method Arterial Spin Labeling (ASL) | Change from placebo intervention at 60 minutes after supplement intake | |
Secondary | Appetite-related brain reward activity | Blood oxygenation level-dependent (BOLD)-functional MRI (fMRI) response to food cues | Change from placebo intervention at 40 minutes after supplement intake | |
Secondary | Cognitive Performance | Cambridge Neuropsychological Test Automated Battery (CANTAB) | Change from placebo intervention at 120 minutes after supplement intake | |
Secondary | Brain Perfusion | Transcranial Doppler (TCD) ultrasound will be used to assess the velocity of blood flow through the middle cerebral artery (MCA) | Change from placebo intervention at 120 minutes after supplement intake | |
Secondary | Blood pressure | Office blood pressure and heart rate | Change from placebo intervention at 90 minutes after supplement intake | |
Secondary | Ketone metabolism | Circulating beta-hydroxybutyrate concentrations | During 120 minutes following supplement intake | |
Secondary | Glucose metabolism | Circulating glucose and insulin concentrations | During 120 minutes following supplement intake | |
Secondary | Markers related to low-grade systemic inflammation | Circulating high-sensitive C-reactive protein concentrations | During 120 minutes following supplement intake | |
Secondary | Appetite hormones | Circulating ghrelin concentrations | During 120 minutes following supplement intake | |
Secondary | Perceived hunger and satiety | Visual analogue scale (VAS) questionnaires | During 120 minutes following supplement intake | |
Secondary | Anthropometric measurements | Weight, length, waist and hip circumference | Before supplement intake | |
Secondary | Food intake | Food Frequency Questionnaire to assess food intake over the past month | Once 120 minutes following supplement intake |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT04121728 -
Modulation of Attention in Event Related Potential (ERPs) as a Marker of Early Cognitive Decline by Ginkgo Biloba
|
N/A | |
Active, not recruiting |
NCT03516734 -
Iron-fortified Lentils to Improve Iron (Fe) Status in Bangladesh
|
N/A | |
Not yet recruiting |
NCT05428228 -
Clinical Study to Evaluate the Effects of Two Novel Hydration Beverage Formulas on Rehydration in Healthy Adults
|
N/A | |
Completed |
NCT05073406 -
Cognition at Altitude in HEMS - Part II
|
N/A | |
Completed |
NCT05498129 -
School Feeding to Improve Cognitive Performance in Disadvantaged Children
|
N/A | |
Completed |
NCT05226039 -
The Effects of a Single Bout of Aerobic Exercise on Cognition: The Moderating Role of Age
|
N/A | |
Completed |
NCT03169283 -
Investigation of How Morning Nutrition Influences Cognitive Performance
|
N/A | |
Completed |
NCT01794351 -
Cognitive Effects of 500mg Trans-resveratrol
|
N/A | |
Completed |
NCT02051153 -
Neurochemical Modulation Cognitive Performance and Subjective Wellbeing In Healthy Controls
|
N/A | |
Completed |
NCT00607204 -
Examining the Biological Factors That Affect Sleep Duration
|
N/A | |
Terminated |
NCT04056650 -
Assessing the Effectiveness of an N-of-1 Platform Using Study of Cognitive Enhancers
|
Phase 4 | |
Recruiting |
NCT05481424 -
Evaluating the Potentials of Biodynamic Lighting for Home Office Workers
|
N/A | |
Completed |
NCT05281146 -
Production of Fortified Biscuit With Chickpea and Crushed Peanut for Improving Cognitive Performance
|
N/A | |
Completed |
NCT00395668 -
TETRA (Terrestrial Trunked Radio)
|
Phase 4 | |
Active, not recruiting |
NCT03771716 -
Rhythm Experience and Africana Culture Trial
|
N/A | |
Active, not recruiting |
NCT03567343 -
Investigational Test of a New Sleep Supplement
|
N/A | |
Completed |
NCT05032729 -
Nutritional Intervention to Enhance Sleep Quality and Quantity in Athletes
|
N/A | |
Completed |
NCT04676542 -
The Effects of Externally Paced Exercise on Cognitive Performance and Stress in College Aged Students
|
N/A | |
Not yet recruiting |
NCT05904431 -
The Effect of Cognitive Performance on Physical Performance in Adolescent Basketball Players
|
||
Completed |
NCT04974606 -
Effect of Coffeeberry on Mood, Motivation and Cognitive Performance
|
N/A |